Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Non-Current Deffered Revenue (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Non-Current Deffered Revenue for 11 consecutive years, with $866000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deffered Revenue rose 368.11% to $866000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $866000.0, a 368.11% increase, with the full-year FY2024 number at $928000.0, up 335.68% from a year prior.
  • Non-Current Deffered Revenue was $866000.0 for Q3 2025 at Gyre Therapeutics, down from $884000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $928000.0 in Q4 2024 to a low of $118000.0 in Q4 2022.
  • A 4-year average of $499333.3 and a median of $213000.0 in 2023 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: surged 80.51% in 2023, then soared 368.11% in 2025.
  • Gyre Therapeutics' Non-Current Deffered Revenue stood at $118000.0 in 2022, then soared by 80.51% to $213000.0 in 2023, then soared by 335.68% to $928000.0 in 2024, then dropped by 6.68% to $866000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Non-Current Deffered Revenue are $866000.0 (Q3 2025), $884000.0 (Q2 2025), and $905000.0 (Q1 2025).